Manulife (Manufacturers Life Insurance)’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-10,400
Closed -$611K 3026
2023
Q4
$611K Sell
10,400
-79,763
-88% -$4.69M ﹤0.01% 2083
2023
Q3
$3.93M Buy
90,163
+35,015
+63% +$1.53M ﹤0.01% 1218
2023
Q2
$1.99M Buy
55,148
+3,769
+7% +$136K ﹤0.01% 1416
2023
Q1
$1.91M Buy
51,379
+13,559
+36% +$504K ﹤0.01% 1414
2022
Q4
$1.62M Buy
37,820
+16,300
+76% +$698K ﹤0.01% 1441
2022
Q3
$1.51M Sell
21,520
-31
-0.1% -$2.17K ﹤0.01% 1461
2022
Q2
$1.45M Sell
21,551
-6,351
-23% -$427K ﹤0.01% 1501
2022
Q1
$2.32M Buy
+27,902
New +$2.32M ﹤0.01% 1463
2021
Q2
Sell
-23,089
Closed -$3.96M 3316
2021
Q1
$3.96M Sell
23,089
-1,476
-6% -$253K ﹤0.01% 1353
2020
Q4
$5.4M Buy
24,565
+3,749
+18% +$823K 0.01% 1179
2020
Q3
$3.46M Sell
20,816
-233
-1% -$38.7K ﹤0.01% 1259
2020
Q2
$2.41M Buy
21,049
+3,260
+18% +$374K ﹤0.01% 1356
2020
Q1
$1.37M Buy
17,789
+2,208
+14% +$170K ﹤0.01% 1426
2019
Q4
$2.01M Sell
15,581
-305
-2% -$39.3K ﹤0.01% 1395
2019
Q3
$1.34M Buy
15,886
+1,075
+7% +$90.7K ﹤0.01% 1514
2019
Q2
$1.53M Buy
14,811
+1,454
+11% +$150K ﹤0.01% 1464
2019
Q1
$979K Buy
13,357
+1,115
+9% +$81.7K ﹤0.01% 1712
2018
Q4
$519K Sell
12,242
-390
-3% -$16.5K ﹤0.01% 1936
2018
Q3
$595K Sell
12,632
-408
-3% -$19.2K ﹤0.01% 2157
2018
Q2
$643K Buy
+13,040
New +$643K ﹤0.01% 2189
2016
Q2
Sell
-7,194
Closed -$149K 4356
2016
Q1
$149K Buy
7,194
+443
+7% +$9.18K ﹤0.01% 2811
2015
Q4
$214 Buy
6,751
+331
+5% +$10 ﹤0.01% 2613
2015
Q3
$221 Hold
6,420
﹤0.01% 2571
2015
Q2
$202 Buy
6,420
+868
+16% +$27 ﹤0.01% 2836
2015
Q1
$162 Buy
5,552
+2,476
+80% +$72 ﹤0.01% 2902
2014
Q4
$57 Sell
3,076
-498
-14% -$9 ﹤0.01% 3202
2014
Q3
$63 Sell
3,574
-1,494
-29% -$26 ﹤0.01% 3241
2014
Q2
$101K Buy
+5,068
New +$101K ﹤0.01% 3137